.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India recently launched its national HPV vaccination campaign to combat cervical cancer among adolescent girls. Prime Minister Narendra Modi inaugurated the initiative in Ajmer, Rajasthan. This landmark step reflects India's strong commitment to women's health. Consequently, the World Health Organization (WHO) congratulated the nation on this massive public health milestone. The move signals a decisive shift in the country's public health journey.
The program targets approximately 1.15 crore girls aged 14 every year. Therefore, it aims to reduce the heavy burden of cervical cancer in the region significantly. Currently, cervical cancer claims a woman's life every two minutes globally. India carries nearly one-quarter of this global burden. Specifically, the government will provide the vaccine free of cost at designated facilities. This ensures equity and protection for all daughters of the country.
Furthermore, this rollout aligns with the global 90-70-90 targets for 2030. These targets involve vaccinating 90% of girls by age 15. Additionally, they include screening 70% of women twice by ages 35 and 45. Finally, 90% of women with cervical disease must receive appropriate treatment. India's effort will accelerate regional momentum toward eliminating this disease as a public health problem.
Q1: Who is the target audience for the HPV vaccination campaign?
The campaign primarily targets approximately 1.15 crore girls aged 14 years across all States and Union Territories annually.
Q2: Is the HPV vaccine provided for free in India?
Yes, the vaccine is provided free of cost at designated Government health facilities as part of this national initiative.
Q3: What are the WHO 90-70-90 targets mentioned?
The 2030 targets aim to vaccinate 90% of girls by age 15, screen 70% of women, and treat 90% of those with cervical cancer or pre-cancer.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India launches a national HPV vaccination campaign targeting 1.15 crore girls annually to eliminate cervical cancer and meet WHO global targets by 2030....
6 months ago
A large NHANES cohort study reveals that higher Healthy Eating Index scores significantly reduce all-cause mortality risk in CKD patients by 45%. This analysis highlights the importance of comprehensive diet quality and medical nutrition therapy in renal care to optimize long-term clinical survival.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Today
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
